A phase I pharmacokinetic study of topiramate extended-release in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 12 Apr 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Apr 2024 According to a Ligand Pharmaceuticals media release, today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc presented preliminary pharmacokinetic data from 25 healthy participants in a poster which was featured at the 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference in London, England.
24 Jun 2013 Results will be presented at the 30th International Epilepsy Congress (IEC) in 2013.
02 Dec 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com